Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Absorption spectroscopy (1)
- Adjuvants (1)
- Anti-bacterial agents - pharmacology (1)
- Antibiotics (1)
- Antimicrobial cationic peptides - pharmacology (1)
-
- Antineoplastic agents - pharmacology (1)
- Antineoplastic drugs (1)
- Apoptosis (1)
- Atomic absorption spectroscopy (AAS) (1)
- Bacterial infections (1)
- Binding (1)
- Biology and life sciences (1)
- Cancer therapies (1)
- Caspase-cleaved prostate apoptosis response (cl-Par-4) (1)
- Caspases (1)
- Cell line (1)
- Chemotherapy (1)
- Circular dichroism (1)
- Circular dichroism (CD) spectroscopy (1)
- Cisplatin (1)
- Cisplatin - chemistry (1)
- Cisplatin - pharmacology (1)
- Clostridioides difficile (1)
- Clostridium (1)
- Clostriodioides (1)
- DNA (1)
- Diagnosis (1)
- Dichroism (1)
- Direct interaction (1)
- Dosage and administration (1)
Articles 1 - 2 of 2
Full-Text Articles in Life Sciences
Host-Defense Piscidin Peptides As Antibiotic Adjuvants Against Clostridioides Difficile, Adenrele Oludiran, Areej Malik, Andriana C. Zourou, Yonghan Wu, Steven P. Gross, Albert Siryapon, Asia Poudel, Kwincy Alleyne, Savion Adams, David S. Courson, Myriam L. Cotten, Erin B. Purcell
Host-Defense Piscidin Peptides As Antibiotic Adjuvants Against Clostridioides Difficile, Adenrele Oludiran, Areej Malik, Andriana C. Zourou, Yonghan Wu, Steven P. Gross, Albert Siryapon, Asia Poudel, Kwincy Alleyne, Savion Adams, David S. Courson, Myriam L. Cotten, Erin B. Purcell
Chemistry & Biochemistry Faculty Publications
The spore-forming intestinal pathogen Clostridioides difficile causes multidrug resistant infection with a high rate of recurrence after treatment. Piscidins 1 (p1) and 3 (p3), cationic host defense peptides with micromolar cytotoxicity against C. difficile, sensitize C. difficile to clinically relevant antibiotics tested at sublethal concentrations. Both peptides bind to Cu2+ using an amino terminal copper and nickel binding motif. Here, we investigate the two peptides in the apo and holo states as antibiotic adjuvants against an epidemic strain of C. difficile. We find that the presence of the peptides leads to lower doses of …
Evidence Of Direct Interaction Between Cisplatin And The Caspase-Cleaved Prostate Apoptosis Response-4 Tumor Suppressor, Krishna K. Raut, Samjhana Pandey, Gyanendra Kharel, Steven M. Pascal
Evidence Of Direct Interaction Between Cisplatin And The Caspase-Cleaved Prostate Apoptosis Response-4 Tumor Suppressor, Krishna K. Raut, Samjhana Pandey, Gyanendra Kharel, Steven M. Pascal
Chemistry & Biochemistry Faculty Publications
Prostate apoptosis response-4 (Par-4) tumor suppressor protein has gained attention as a potential therapeutic target owing to its unique ability to selectively induce apoptosis in cancer cells, sensitize them to chemotherapy and radiotherapy, and mitigate drug resistance. It has recently been reported that Par-4 interacts synergistically with cisplatin, a widely used anticancer drug. However, the mechanistic details underlying this relationship remain elusive. In this investigation, we employed an array of biophysical techniques, including circular dichroism spectroscopy, dynamic light scattering, and UV–vis absorption spectroscopy, to characterize the interaction between the active caspase-cleaved Par-4 (cl-Par-4) fragment and cisplatin. Additionally, elemental analysis was …